Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-10-29

Clinical Trial Update: Head-to-Head Harmonization of Tau Tracers in Alzheimer's Disease [Phase 1]

View source ↗

Summary

Phase 1 study evaluating head-to-head harmonization of tau PET tracers in Alzheimer's disease is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Tharick Pascoal | Conditions: Alzheimer Disease | Phase 1 | Status: ACTIVE_NOT_RECRUITING